Bethesda, MD, United States of America

Alan Thomas Remaley

USPTO Granted Patents = 18 

 

 

Average Co-Inventor Count = 3.9

ph-index = 2

Forward Citations = 84(Granted Patents)


Company Filing History:


Years Active: 2000-2024

Loading Chart...
Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: Alan Thomas Remaley: Innovator in Lipoprotein Targeting Therapies

Introduction: Alan Thomas Remaley is a distinguished inventor based in Bethesda, MD, recognized for his significant contributions to biomedical innovation. With an impressive portfolio of 18 patents, his work primarily revolves around advancements in lipoprotein targeting and protease inhibitors, which hold promise in treating various health conditions.

Latest Patents: Among his latest innovations are groundbreaking patents that include "Lipoprotein targeting protease inhibitors and uses." This patent outlines the design and construction of a class of lipoprotein targeting protease inhibitors, where small peptides with protease inhibitor activity are conjugated to hydrophobic, lipoprotein targeting molecules. The patent also describes the production of protease inhibitor enriched HDL particles and their applications in therapeutic contexts.

Additionally, his patent on "ApoC-II mimetic peptides" provides novel solutions for treating hypertriglyceridemia. This disclosure includes methods for utilizing effective amounts of apoC-II mimetic peptides, offering new approaches to managing this condition.

Career Highlights: Alan has collaborated extensively with notable organizations, including the Government of the United States of America as represented by the Secretary of the Department of Health and Human Services and Unm Rainforest Innovations. His contributions have not only advanced scientific research but have also enhanced the potential for practical applications in healthcare.

Collaborations: Throughout his career, Alan has worked alongside esteemed colleagues such as Marcelo Amar and Bryce Chackerian. Their collective expertise has fostered innovation and has been pivotal in driving the success of their collaborative endeavors.

Conclusion: Alan Thomas Remaley continues to be a prominent figure in the field of biomedical innovations. His dedication to developing novel therapeutics through his patents underscores the importance of scientific research in addressing critical health challenges. As he forges ahead, his work remains a beacon of ingenuity and progress in modern medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…